Back

Finerenone in patients with heart failure and diabetic kidney disease: comparison of mineralocorticoid receptor antagonists. FINARM study

1 September 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (4) - Pharmacotherapy for heart failure (1) Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Edison Omar Boada Lincango

A Coruna University Hospital, A Coruna (Spain)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor B. Muk (Budapest, HU)
Abstract
Presentation thumbnail
Doctor P. Amornritvanich (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Doctor A. Urbinati (New York, US)
Abstract Slides
Presentation thumbnail
Doctor F. Banfi-Bacsardi (Budapest, HU)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (4) - Pharmacotherapy for heart failure (1)

The Event

Event poster

ESC Congress 2025

1 September 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Early experience with finerenone in patients with heart failure and diabetic kidney disease: 6 months of real-world cohort follow-up
thumbnail
Congress Presentation
Non-steroidal MRAs in heart failure and cardio-kidney-metabolic disease: current clinical trial evidence
thumbnail
Congress Presentation
FINEARTS-HF - Finerenone in heart failure with mildly reduced and preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources